Journal article
Cancer Immunotherapy: PD‐1 Blockade Cellular Vesicles for Cancer Immunotherapy (Adv. Mater. 22/2018)
Advanced materials (Weinheim), v 30(22), 1870152
01 May 2018
Abstract
In article number 1707112, Peng Huang, Zhen Gu, and co‐workers engineer cellular nanovesicles presenting PD‐1 receptors on their membranes, which enhance antitumor response by disrupting the PD‐1/PD‐L1 immune inhibitory axis. These nanovesicles could also be adapted to carry a variety of therapeutics to achieve synergistic cancer therapy.
Metrics
6 Record Views
Details
- Title
- Cancer Immunotherapy: PD‐1 Blockade Cellular Vesicles for Cancer Immunotherapy (Adv. Mater. 22/2018)
- Creators
- Xudong Zhang - University of North Carolina at Chapel HillChao Wang - University of North Carolina at Chapel HillJinqiang Wang - University of North Carolina at Chapel HillQuanyin Hu - University of North Carolina at Chapel HillBenjamin Langworthy - University of North Carolina at Chapel HillYanqi Ye - University of North Carolina at Chapel HillWujin Sun - University of North Carolina at Chapel HillJing Lin - Shenzhen University Health Science CenterTianfu Wang - Shenzhen University Health Science CenterJason Fine - University of North Carolina at Chapel HillHao Cheng - Drexel UniversityGianpietro Dotti - University of North Carolina at Chapel HillPeng Huang - Shenzhen University Health Science CenterZhen Gu - University of North Carolina at Chapel Hill
- Publication Details
- Advanced materials (Weinheim), v 30(22), 1870152
- Publisher
- Wiley
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Materials Science and Engineering
- Other Identifier
- 991021886367304721